Latest News

Alpha Cognition Inc. Advances Alzheimer's Treatment with ZUNVEYL® in Texas and Beyond
Alpha Cognition Inc. reports significant progress in the commercialization of ZUNVEYL®, its Alzheimer's disease treatment, with early adoption in the U.S. long-term care market and a key Medicare Part …